Insmed Inc (INSM)

[cashquest2003]

GBK,

I appriciate your opinion on BP3, and it makes sense. One would think if something was there, INSM would have partnered it, as going it alone is cost prohibitive.

If I may ask, you are a man of some experience in biotech. What do you feel of our current situation? Do you think this will get settled or actually go to trial? If we really loose, is it at max a 5-10% royality and no chance much of an injunction? Why haven't we yet seen a European partner? Is INSM going to smash TRCA in sales as so many here seem to feel is about to become evident in the next few quarters? How do you feel about Muscular Distrophy and Insulin resistance as successful clinical trial outcomes? I for one feel Muscular Distrophy data should be out very soon, and I'm hopping it is positive, as I don't think the Muscular Distrophy Association and the National Instute of Health would have pumped millions into this research if the outcome was not forgone.

I realized I have asked many a question and some big ones, and I'm not in your knowledge class. I only seek opinion and knowledge, as being invested in this sock has been such a great learning expeience. I have held 9k shares for about 3 years now, and for me that's a lot. I believe this will hit $5+ if the suit gets settled in a positive manor, INSM does pull ahead in sales, and Muscular Distrophy going for approval in the future is a likely reality. What of you?

Sincere regards, and I have always enjoyed your contributions,

Jon